Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026)
Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 146.00 |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -867.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,292.00 |
| Dec 31, 2025 | -1,301.00 |
| Sep 30, 2025 | 1,523.00 |
| Jun 30, 2025 | 632.00 |
| Mar 31, 2025 | -11.00 |
| Dec 31, 2024 | 2,503.00 |
| Sep 30, 2024 | -73.00 |
| Jun 30, 2024 | -1,601.00 |
| Mar 31, 2024 | -1,203.00 |
| Dec 31, 2023 | 1,284.00 |
| Sep 30, 2023 | 2,015.00 |
| Jun 30, 2023 | 4,267.00 |
| Mar 31, 2023 | 2,605.00 |
| Dec 31, 2022 | 2,637.00 |
| Sep 30, 2022 | -179.00 |
| Jun 30, 2022 | -2,746.00 |
| Mar 31, 2022 | 5,308.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 4,817.00 |
| Jun 30, 2021 | 8,639.00 |